NRF Gene Test (Nrf2, Oxidative Stress, Detoxification & Cellular Defence)

• Identify whether you carry NRF2 (NFE2L2) promoter and functional variants that alter transcriptional activity and expression of antioxidant and detoxification enzymes.
• Help explain why you may be more or less sensitive to oxidative stressors such as pollution, smoking, intense exercise, certain medications or occupational exposures.
• Inform personalised strategies around diet (especially polyphenols and cruciferous vegetables), supplementation, training load and recovery to support antioxidant defences and healthy ageing.
• Provide context for cardiometabolic, neurodegenerative and inflammatory risk where oxidative stress plays a central role.
• Clarify your baseline cellular defence capacity alongside blood markers, lifestyle and symptoms, so prevention and performance plans can be grounded in your biology.

In this context, NRF refers primarily to nuclear factor erythroid 2‑related factor 2 (NRF2), encoded by the NFE2L2 gene. NRF2 is a basic leucine zipper transcription factor that binds to antioxidant response elements in the promoters of many cytoprotective genes. Under steady‑state conditions, it is held in check by its negative regulator KEAP1 and targeted for degradation.

When cells experience oxidative or electrophilic stress, NRF2 stabilises, accumulates in the nucleus and partners with small Maf proteins to drive expression of phase II detoxification enzymes, antioxidant systems, drug‑metabolising and xenobiotic transport proteins, and other stress‑response genes. NRF2 is therefore a master regulator of the endogenous antioxidant and detoxification network.

NRF2 sits at the core of the cellular defence response. Once activated, it binds to antioxidant response elements and increases transcription of genes involved in glutathione synthesis and recycling, the thioredoxin system, NADPH regeneration, heme metabolism, and phase I and II detoxification enzymes, along with transporters that export metabolites and toxins.

Through these targets, NRF2 enhances the ability of cells to neutralise reactive oxygen species, repair damage, and adapt to environmental and metabolic stress. It also modulates inflammatory signalling, mitochondrial function, autophagy, proteostasis and intermediary metabolism. Polymorphisms in NFE2L2 can change the efficiency of these responses, influencing susceptibility to vascular damage, kidney disease, lung injury, neurodegeneration and other conditions where oxidative stress is a driver.

NRF2 contributes to three interconnected systems: antioxidant and detoxification capacity, inflammatory and immune regulation, and long‑term cardiometabolic and brain health. A robust NRF2 response protects lipids, proteins and DNA from oxidative damage, supports healthy endothelial function and helps maintain mitochondrial integrity.

Variants that reduce NRF2 transcriptional activity or responsiveness can blunt this protective system, potentially increasing vulnerability to vascular oxidative stress, environmental toxins, drug‑induced damage and chronic inflammatory conditions, particularly in high‑exposure settings. Conversely, in some cancers NRF2 can be aberrantly activated and support tumour survival, highlighting the importance of context. For most people seeking prevention, the focus is on ensuring adequate NRF2‑driven protection without chronic pathological overactivation.

It is easy to assume that NRF genotyping and oxidative stress or liver detoxification panels measure the same thing, but they answer different questions. NRF genotyping looks at your inherited potential to activate NRF2‑driven antioxidant and detoxification pathways. This capacity is relatively stable across life, though it can be modulated up or down by exposures and lifestyle.

Oxidative stress markers, antioxidant levels and liver function tests show how your defences and detoxification systems are coping now, under your current diet, exposures, medications, sleep and training. You can have NRF2 patterns associated with lower baseline protection but maintain good oxidative balance through lifestyle, and you can have favourable NRF2 variants but still experience high oxidative stress under heavy exposure, poor diet or illness. Both perspectives are valuable when designing a strategy.

The influence of NRF variants is shaped strongly by lifestyle, exposures and co‑existing conditions. Several modifiable factors can either buffer a weaker NRF2 profile or maximise a stronger one.

• Diet quality and phytonutrients: Diets rich in colourful plant foods, cruciferous vegetables, herbs and spices provide compounds that can support NRF2 activation and antioxidant defences. Low‑plant, ultra‑processed diets increase oxidative stress and reduce resilience.
• Smoking, pollution and occupational toxins: Tobacco smoke, air pollution, heavy metals and industrial chemicals create a high oxidative load. In people with weaker NRF2 activity, these exposures can be particularly harmful, making avoidance and protection critical.
• Physical activity pattern: Regular moderate exercise upregulates antioxidant defences and NRF2 pathways over time, while unaccustomed extreme exertion without recovery can cause excessive oxidative damage. Well‑designed training helps balance this hormetic response.
• Metabolic health and inflammation: Obesity, insulin resistance and chronic inflammation raise oxidative stress and demand on NRF2‑dependent systems. Improving metabolic health reduces this burden.
• Medications and xenobiotics: Some drugs and chemicals are processed through NRF2‑regulated pathways. Polypharmacy or specific agents can increase detoxification and antioxidant demand.
• Sleep, stress and recovery: Poor sleep and chronic psychological stress increase oxidative and inflammatory signalling, while good sleep and stress management support recovery of antioxidant capacity.

Yes. Many individuals with NRF2 promoter or functional variants never develop obvious symptoms that they can directly attribute to this gene. Instead, differences typically appear in how they respond to exposures over years, in blood markers and in disease risk under stress.

In a low‑exposure, high‑nutrition lifestyle, even a relatively weaker NRF2 pattern may not translate into overt problems. In contrast, heavy exposures, poor diet, smoking or uncontrolled metabolic disease can reveal these vulnerabilities through earlier vascular issues, organ damage or reduced resilience to toxins or infections.

NRF2 (NFE2L2) genotypes mainly differ in promoter and regulatory polymorphisms that alter transcriptional activity, as well as coding variants and splice changes that can affect protein stability or KEAP1 interaction.

• Promoter polymorphisms (for example in antioxidant response and other binding sites): Certain NFE2L2 promoter variants reduce transcriptional activity by weakening NRF2 or other factor binding to its own promoter. These have been associated with lower NRF2‑dependent gene expression and higher blood pressure or vascular risk in some populations, likely via reduced protection against oxidative stress.
• Functional variants affecting KEAP1 interaction or stability: Changes that alter the KEAP1 binding domain or degradation signals can increase or decrease NRF2 stability, impacting baseline and induced activity. Strong gain‑of‑function variants are more often seen in cancers, where they can support tumour survival.
• Autoregulatory and co‑factor interactions: NRF2 can autoregulate its transcription through antioxidant response elements in its own promoter and is influenced by other transcription factors such as NF‑κB and AhR, so variants in these networks can modulate NRF2 activity indirectly.
• Related NRF family members: In some panels, NRF may also include nuclear respiratory factors (NRF1/NRF2) involved in mitochondrial biogenesis. Their variants influence mitochondrial mass, function and resilience but sit alongside NFE2L2 rather than replacing it.

For DNA‑based NRF testing, preparation is simple because genotype does not change with diet, exposures or medications. The key step is clarifying how you intend to use the information, for example to refine your exposure management, dietary pattern, supplementation and training approach.

Cheek swab, saliva or blood‑based NRF genotyping does not require fasting. If you are also undergoing oxidative stress panels, antioxidant levels, liver function or cardiometabolic tests, follow the preparation instructions for those, which may include fasting, avoiding alcohol and intense exercise shortly beforehand.

An NRF test is most useful when the result will meaningfully change how you manage exposures, diet, training and prevention, rather than as a curiosity. It becomes particularly informative when interpreted alongside lifestyle, environment and biomarker data.

• High exposure or occupational risk: People with significant pollution, chemical or occupational exposures may benefit from understanding NRF2‑related resilience to guide protective measures and monitoring.
• Cardiometabolic and vascular risk: In those with hypertension, kidney disease, diabetes or strong family history of vascular disease, NRF can help anchor oxidative stress as a prevention target within a broader plan.
• Performance and recovery focus: Athletes and highly active individuals can use NRF insights to balance training stress with recovery and antioxidant support, especially when undertaking heavy loads, heat, altitude or travel.
• Comprehensive prevention and longevity planning: Within wider DNA and biomarker programmes, NRF2 is a core node for integrating antioxidant, detoxification, mitochondrial and inflammatory strategies.